Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Conditions

• AIDS-Related Diffuse Large B-cell Lymphoma
• AIDS-Related Non-Hodgkin Lymphoma
• HIV Infection
• Recurrent Diffuse Large B-Cell Lymphoma
• Recurrent Grade 3b Follicular Lymphoma
• Recurrent High Grade B-Cell Lymphoma
• Recurrent Non-Hodgkin Lymphoma
• Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
• Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
• Refractory Diffuse Large B-Cell Lymphoma
• Refractory Grade 3b Follicular Lymphoma
• Refractory High Grade B-Cell Lymphoma
• Refractory Non-Hodgkin Lymphoma
• Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma
• Refractory Transformed B-Cell Non-Hodgkin Lymphoma

Interventions

• BIOLOGICAL: Axicabtagene Ciloleucel
• DRUG: Cyclophosphamide
• DRUG: Fludarabine

Sponsor

AIDS Malignancy Consortium

Collaborators

• [object Object]
• [object Object]